Related Articles
Targeting drug resistance in glioblastoma (Review)
Hedgehog signaling regulates the development and treatment of glioblastoma (Review)
Progress of immune checkpoint LAG‑3 in immunotherapy (Review)
Biomarkers to predict the benefits of immune‑checkpoint blockade‑based therapy in patients with malignant peritoneal mesothelioma (Review)
Nanomedicine to modulate immunotherapy in cutaneous melanoma (Review)